Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Imprimis Phar (IMMY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Analysis: Positioning to Benefit within Abeona Therapeutics, Great Lakes Dredge & Dock, Imprimis Pharmaceuticals, Alliant Energy, Cytokinetics, and Aurinia Pharmaceuticals -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Abeona Therapeutics Inc. (NASDAQ:ABEO),...

IMMY : 5.83 (-2.02%)
CYTK : 7.70 (-2.65%)
AUPH : 6.01 (-1.15%)
LNT : 45.32 (-1.73%)
GLDD : 7.31 (-2.27%)
ABEO : 7.36 (-2.84%)
4 Healthcare Stocks Taking a New Approach to Growth Trends

CORAL GABLES, FL / ACCESSWIRE / November 19, 2018 / have rallied during the last 3 trading sessions. The Select Sector SPDR Healthcare ETF (XLV) has climbed from lows of $88.83 on Thursday to as high...

IMMY : 5.83 (-2.02%)
LCI : 4.85 (-4.53%)
AEZS : 2.85 (-6.56%)
PHGI.CN : 0.960 (-1.03%)
PHGRF : 0.7378 (-0.04%)
Imprimis Pharmaceuticals Ranked 88th Fastest Growing Company in North America on Deloitte's 2018 Technology Fast 500(TM)

Imprimis attributes growth to its vision of making sure patients have access to high quality affordable medications

IMMY : 5.83 (-2.02%)
ETON : 6.00 (-0.17%)
4 Healthcare Stocks Investors Should Get Familiar With

CORAL GABLES, FL / ACCESSWIRE / November 14, 2018 / The is the sector of the economy made up of companies that specialize in products and services related to health and medical care. According to reports...

IMMY : 5.83 (-2.02%)
TDOC : 51.17 (-2.44%)
RSLS : 0.51 (unch)
Imprimis: 3Q Earnings Snapshot

SAN DIEGO (AP) _ Imprimis Pharmaceuticals Inc. (IMMY) on Tuesday reported a loss of $2.5 million in its third quarter.

IMMY : 5.83 (-2.02%)
Imprimis Pharmaceuticals Announces Third Quarter 2018 Results

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today reported results for the third quarter 2018.

IMMY : 5.83 (-2.02%)
ETON : 6.00 (-0.17%)
Analysis: Positioning to Benefit within Kopin, MDC Partners, Dova Pharmaceuticals, Revlon, Imprimis Pharmaceuticals, and Minerva Neurosciences -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Kopin Corporation (NASDAQ:KOPN),...

KOPN : 1.41 (-1.40%)
MDCA : 2.90 (-1.69%)
REV : 24.95 (-3.37%)
IMMY : 5.83 (-2.02%)
DOVA : 14.81 (-0.54%)
NERV : 7.84 (+0.26%)
ImprimisRx to feature new formulation and poster presentation on MKO Melt(R) at the upcoming American Academy of Ophthalmology Meeting in Chicago

Poster on data from a 611-patient study featuring Imprimis's MKO Melt to be presented

IMMY : 5.83 (-2.02%)
Imprimis: 1Q Earnings Snapshot

SAN DIEGO (AP) _ Imprimis Pharmaceuticals Inc. (IMMY) on Tuesday reported a loss of $3.5 million in its first quarter.

IMMY : 5.83 (-2.02%)
Imprimis Pharmaceuticals Announces First Quarter 2018 Results

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today reported financial results for the first quarter 2018.

IMMY : 5.83 (-2.02%)
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners

Surface Pharmaceuticals, Inc., an affiliated company of Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), today announced it has entered into a definitive stock purchase agreement with an affiliate of Flying...

IMMY : 5.83 (-2.02%)
Research Report Identifies Albany International, JBG SMITH Properties, Preferred Apartment Communities, National Western Life Group, Phibro Animal Health, and Imprimis Pharmaceuticals with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Albany International Corporation...

APTS : 14.75 (-0.67%)
NWLI : 298.09 (-0.34%)
IMMY : 5.83 (-2.02%)
AIN : 67.51 (-1.11%)
JBGS : 37.42 (-0.90%)
PAHC : 32.95 (+0.12%)
Imprimis Pharmaceuticals to feature its patent-pending cyclosporine/chondroitin sulfate and patented non-opioid MKO Melt® (midazolam/ketamine/ondansetron) formulations at the upcoming Cataract & Refractive Surgery Medical Meeting

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), and its ophthalmology-focused ImprimisRx division, today announced its participation and related physician presentations at the 2018 American Society of Cataract...

IMMY : 5.83 (-2.02%)
Imprimis Pharmaceuticals Issued Composition Patent for Non-Opioid Conscious Sedation Formulation

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, today announced it has secured a patent covering the company's innovative MKO (midazolam, ketamine, and ondansetron)...

IMMY : 5.83 (-2.02%)
Analysis: Positioning to Benefit within Enbridge Energy Management, Imprimis Pharmaceuticals, Hibbett Sports, Glacier, Regis, and Fox Factory Holding -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Enbridge Energy Management...

EEQ : 10.71 (-1.02%)
HIBB : 13.90 (-3.20%)
GBCI : 42.32 (-2.26%)
IMMY : 5.83 (-2.02%)
FOXF : 61.48 (-4.01%)
RGS : 15.93 (-1.91%)
Imprimis reports 4Q loss

SAN DIEGO (AP) _ Imprimis Pharmaceuticals Inc. (IMMY) on Thursday reported a loss of $2.8 million in its fourth quarter.

IMMY : 5.83 (-2.02%)
Imprimis Pharmaceuticals Announces Fourth Quarter 2017 Results

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, today reported financial results for the fourth quarter 2017.

IMMY : 5.83 (-2.02%)
Wired News - Imprimis Pharma Launched New Program for Custom Compounded Ophthalmic Medications

Stock Monitor: Akcea Therapeutics Post Earnings Reporting

IMMY : 5.83 (-2.02%)
AKCA : 31.16 (-1.39%)
Imprimis Pharmaceuticals to Present at 30th Annual ROTH Conference on March 13, 2018

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, today announced that its Chief Executive Officer, Mark L. Baum, will present an update on the company's business...

IMMY : 5.83 (-2.02%)

Van Meerten Stock Picks

Tesla According to Peter Lynch
Today's Barchart Chart of the Day will be the auto maker Tesla (TSLA).
TSLA -11.08
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

cmdty Insider - Ag Market Commentary

Today's Commentary

Corn futures ended the Friday session with most contracts steady to 1/2 cent higher, as Dec expired at $3.76 3/4. USDA reported a private export sale of 125,000 MT of corn to Japan this morning. Corn export commitments through December 6 were 16.3% l...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar